{"id":"NCT01318083","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan","officialTitle":"A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 When Used in Combination With Sulfonylurea in Subjects With Type 2 Diabetes in Japan","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-08","primaryCompletion":"2009-04","completion":"2009-04","firstPosted":"2011-03-18","resultsPosted":"2011-07-06","lastUpdate":"2012-02-03"},"enrollment":312,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and glimepiride","otherNames":["SYR-322","Amaryl"]},{"type":"DRUG","name":"Alogliptin and glimepiride","otherNames":["SYR-322","Amaryl"]},{"type":"DRUG","name":"Glimepiride","otherNames":["Amaryl"]}],"arms":[{"label":"Alogliptin 12.5 mg QD and Glimepiride QD or BID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 25 mg QD and Glimepiride QD or BID","type":"ACTIVE_COMPARATOR"},{"label":"Glimepiride 1, 2, 3 or 4 mg QD or BID","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was evaluate the efficacy and safety of alogliptin, once daily (QD) combined with an Sulfonylurea taken QD or twice daily (BID) in type 2 diabetic patients with uncontrolled blood glucose.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (Week 12).","timeFrame":"Baseline and Week 12.","effectByArm":[{"arm":"Alogliptin 12.5 mg QD and Glimepiride QD or BID","deltaMin":-0.6,"sd":0.563},{"arm":"Alogliptin 25 mg QD and Glimepiride QD or BID","deltaMin":-0.66,"sd":0.564},{"arm":"Glimepiride 1, 2, 3 or 4 mg QD or BID","deltaMin":0.34,"sd":0.611}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24843617"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":105},"commonTop":["Nasopharyngitis","Upper respiratory tract inflammation","Fall","Headache","Gastroenteritis"]}}